| FFMMX | IRTCX | FFMMX / IRTCX | |
| Total Expense Ratio | 0.36 | 1.19 | 30% |
| Annual Report Gross Expense Ratio | 0.36 | 1.19 | 30% |
| Fund Existence | 6 years | 6 years | - |
| Gain YTD | 7.210 | 7.063 | 102% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 117B | 3.79B | 3,086% |
| Annual Yield % from dividends | 1.67 | 0.97 | 172% |
| Returns for 1 year | 9.97 | 5.74 | 174% |
| Returns for 3 years | 36.90 | 20.00 | 185% |
| Returns for 5 years | 38.69 | 14.60 | 265% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| STOCK / NAME | Price $ | Chg $ | Chg % |
| PAC | 236.89 | 7.08 | +3.08% |
| Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares) | |||
| ALT | 2.61 | 0.02 | +0.77% |
| Altimmune | |||
| CPIX | 5.60 | -0.07 | -1.23% |
| Cumberland Pharmaceuticals | |||
| AGMH | 1.19 | -0.02 | -1.65% |
| AGM Group Holdings Inc | |||
| SUPN | 44.41 | -1.14 | -2.50% |
| Supernus Pharmaceuticals | |||